Works matching IS 08876924 AND DT 2012 AND VI 26 AND IP 3

Results: 29

(+)[alpha]-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo.

Published in:

2012

By:

dos Santos GA;
Abreu e Lima RS;
Pestana CR;
Lima AS;
Scheucher PS;
Thomé CH;
Gimenes-Teixeira HL;
Santana-Lemos BA;
Lucena-Araujo AR;
Rodrigues FP;
Nasr R;
Uyemura SA;
Falcao RP;
de Thé H;
Pandolfi PP;
Curti C;
Rego EM

Publication type:

Journal Article

Functional role of BAALC in leukemogenesis.

Published in:

2012

By:

Heuser, M;
Berg, T;
Kuchenbauer, F;
Lai, C K;
Park, G;
Fung, S;
Lin, G;
Leung, M;
Krauter, J;
Ganser, A;
Humphries, R K

Publication type:

Letter

Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 424, doi. 10.1038/leu.2011.237

By:

Krejsgaard, T;
Odum, N;
Geisler, C;
Wasik, M A;
Woetmann, A

Publication type:

Article

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.

Published in:

2012

By:

Visconte, V;
Makishima, H;
Jankowska, A;
Szpurka, H;
Traina, F;
Jerez, A;
O'Keefe, C;
Rogers, H J;
Sekeres, M A;
Maciejewski, J P;
Tiu, R V

Publication type:

Letter

The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations.

Published in:

2012

By:

Tiacci, E;
Spanhol-Rosseto, A;
Martelli, M P;
Pasqualucci, L;
Quentmeier, H;
Grossmann, V;
Drexler, H G;
Falini, B

Publication type:

Letter

Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 414, doi. 10.1038/leu.2011.387

By:

Luis, T C;
Ichii, M;
Brugman, M H;
Kincade, P;
Staal, F J T

Publication type:

Article

NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.

Published in:

2012

By:

Terwey, T H;
Vega-Ruiz, A;
Hemmati, P G;
Martus, P;
Dietz, E;
le Coutre, P;
Massenkeil, G;
Dörken, B;
Arnold, R

Publication type:

Letter

Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities.

Published in:

2012

By:

Vicente, C;
Vazquez, I;
Conchillo, A;
García-Sánchez, M A;
Marcotegui, N;
Fuster, O;
González, M;
Calasanz, M J;
Lahortiga, I;
Odero, M D

Publication type:

Letter

How to manage lower-risk myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 390, doi. 10.1038/leu.2011.223

By:

Sekeres, M A

Publication type:

Article

(+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 451, doi. 10.1038/leu.2011.216

By:

dos Santos, G A S;
Abreu e Lima, R S;
Pestana, C R;
Lima, A S G;
Scheucher, P S;
Thomé, C H;
Gimenes-Teixeira, H L;
Santana-Lemos, B A A;
Lucena-Araujo, A R;
Rodrigues, F P;
Nasr, R;
Uyemura, S A;
Falcão, R P;
de Thé, H;
Pandolfi, P P;
Curti, C;
Rego, E M

Publication type:

Article

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 481, doi. 10.1038/leu.2011.225

By:

Reddy, M M;
Fernandes, M S;
Deshpande, A;
Weisberg, E;
Inguilizian, H V;
Abdel-Wahab, O;
Kung, A L;
Levine, R L;
Griffin, J D;
Sattler, M

Publication type:

Article

WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission.

Published in:

2012

By:

Hashii, Y;
Sato-Miyashita, E;
Matsumura, R;
Kusuki, S;
Yoshida, H;
Ohta, H;
Hosen, N;
Tsuboi, A;
Oji, Y;
Oka, Y;
Sugiyama, H;
Ozono, K

Publication type:

Letter

NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 465, doi. 10.1038/leu.2011.239

By:

Chen, C I-U;
Koschmieder, S;
Kerstiens, L;
Schemionek, M;
Altvater, B;
Pscherer, S;
Gerss, J;
Maecker, H T;
Berdel, W E;
Juergens, H;
Lee, P P;
Rossig, C

Publication type:

Article

MicroRNAs in inflammation and immune responses.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 404, doi. 10.1038/leu.2011.356

By:

Contreras, J;
Rao, D S

Publication type:

Article

Commentary: does immune suppression increase risk of developing acute myeloid leukemia?

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 422, doi. 10.1038/leu.2011.224

By:

Gale, R P;
Opelz, G

Publication type:

Article

MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 443, doi. 10.1038/leu.2011.246

By:

Carter, B Z;
Mak, D H;
Shi, Y;
Fidler, J M;
Chen, R;
Ling, X;
Plunkett, W;
Andreeff, M

Publication type:

Article

Release of intracellular calcium primes chronic myeloid leukaemia cells for tyrosine kinase inhibitor-induced apoptosis.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 490, doi. 10.1038/leu.2011.231

By:

Forchap, S L;
Pirmohamed, M;
Clark, R E

Publication type:

Article

Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 433, doi. 10.1038/leu.2011.245

By:

Lengfelder, E;
Hofmann, W-K;
Nowak, D

Publication type:

Article

Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 461, doi. 10.1038/leu.2011.229

By:

Ishiyama, K;
Takami, A;
Kanda, Y;
Nakao, S;
Hidaka, M;
Maeda, T;
Naoe, T;
Taniguchi, S;
Kawa, K;
Nagamura, T;
Atsuta, Y;
Sakamaki, H

Publication type:

Article

Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission.

Published in:

2012

By:

Chou, W-C;
Peng, K-Y;
Lei, W-C;
Ko, B-S;
Tsay, W;
Kuo, C-H;
Tien, H-F

Publication type:

Letter

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 520, doi. 10.1038/leu.2011.240

By:

Dodero, A;
Spina, F;
Narni, F;
Patriarca, F;
Cavattoni, I;
Benedetti, F;
Ciceri, F;
Baronciani, D;
Scimè, R;
Pogliani, E;
Rambaldi, A;
Bonifazi, F;
Dalto, S;
Bruno, B;
Corradini, P

Publication type:

Article

Epigenetic regulation of miRNA genes in acute leukemia.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 395, doi. 10.1038/leu.2011.344

By:

Agirre, X;
Martínez-Climent, J Á;
Odero, M D;
Prósper, F

Publication type:

Article

Action of novel CD37 antibodies on chronic lymphocytic leukemia cells.

Published in:

2012

By:

Krause, G;
Patz, M;
Isaeva, P;
Wigger, M;
Baki, I;
Vondey, V;
Kerwien, S;
Kuckertz, M;
Brinker, R;
Claasen, J;
Frenzel, L P;
Wendtner, C-M;
Heider, K-H;
Hallek, M

Publication type:

Letter

Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 509, doi. 10.1038/leu.2011.244

By:

Breuer, S;
Preuner, S;
Fritsch, G;
Daxberger, H;
Koenig, M;
Poetschger, U;
Lawitschka, A;
Peters, C;
Mann, G;
Lion, T;
Matthes-Martin, S

Publication type:

Article

The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status.

Published in:

2012

By:

Tsykunova, G;
Reikvam, H;
Hovland, R;
Bruserud, Ø

Publication type:

Letter

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 381, doi. 10.1038/leu.2011.234

By:

Platzbecker, U;
Wermke, M;
Radke, J;
Oelschlaegel, U;
Seltmann, F;
Kiani, A;
Klut, I-M;
Knoth, H;
Röllig, C;
Schetelig, J;
Mohr, B;
Graehlert, X;
Ehninger, G;
Bornhäuser, M;
Thiede, C

Publication type:

Article

Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 499, doi. 10.1038/leu.2011.247

By:

Ciccone, M;
Agostinelli, C;
Rigolin, G M;
Piccaluga, P P;
Cavazzini, F;
Righi, S;
Sista, M T;
Sofritti, O;
Rizzotto, L;
Sabattini, E;
Fioritoni, G;
Falorio, S;
Stelitano, C;
Olivieri, A;
Attolico, I;
Brugiatelli, M;
Zinzani, P L;
Saccenti, E;
Capello, D;
Negrini, M

Publication type:

Article

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.

Published in:

2012

By:

Launay, E;
Pangault, C;
Bertrand, P;
Jardin, F;
Lamy, T;
Tilly, H;
Tarte, K;
Bastard, C;
Fest, T

Publication type:

Letter

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F.

Published in:

Leukemia (08876924), 2012, v. 26, n. 3, p. 475, doi. 10.1038/leu.2011.253

By:

Tefferi, A;
Jimma, T;
Sulai, N H;
Lasho, T L;
Finke, C M;
Knudson, R A;
McClure, R F;
Pardanani, A

Publication type:

Article